MedWatch

Coloplast doesn't expect impact from potential Russian gas halt

Coloplast has been working on phasing out natural gas use in its factories the world over in recent years, and today the Danish medtech company only uses natural gas to a limited extent.

Photo: Coloplast / PR

Danish medtech firm Coloplast is only expecting to be impacted to a very limited extent by the increasing cost of natural gas. Production issues aren’t in the cards even if the company was cut off from Russian gas completely, Coloplast writes in a comment to MarketWire.

Coloplast, which has factories in sites all over the world, has been phasing out natural gas, meaning the energy source is only used to a limited extent and primarily to heat the company’s facilities.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs